Remove Immune Response Remove Medical Chemistry Remove Research
article thumbnail

How GPCR-targeting therapies are advancing the fight against inflammatory disease

Drug Target Review

Moreover, GPCRs have a complex pharmacology, with each acting as a kind of signalling hub for an array of downstream signals, in contrast to simpler receptors which are generally responsible for one signal. Stephan holds a PhD in medical chemistry from University of Strasbourg in France.

article thumbnail

Outsmarting immune suppression through GPCR innovation

Drug Target Review

With over two decades of experience in biomedical research, he is leading efforts to translate breakthrough GPCR biology into differentiated therapeutic strategies that can overcome immune resistance and offer new hope to patients with limited treatment options. This strategy is exemplified by its flagship programme: DT-7012.